Cargando…

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma

INTRODUCTION: Bevacizumab has demonstrated activity in glioblastoma (GBM), but the true benefits and optimal dose‐schedule are debated. A lower dose‐schedule than standard‐dose bevacizumab (10 mg/kg 2‐weekly) might offer similar benefits with lower costs. At our Institution, patients are randomly as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gleeson, Jack Patrick, Keane, Fergus, Keegan, Niamh M., Mammadov, Emin, Harrold, Emily, Alhusaini, Abdullah, Harte, Jeffrey, Eakin‐Love, Austin, O'Halloran, Philip J., MacNally, Stephen, Hennessy, Bryan T., Breathnach, Oscar S., Grogan, Liam, Morris, Patrick G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970030/ https://www.ncbi.nlm.nih.gov/pubmed/31756059 http://dx.doi.org/10.1002/cam4.2616

Ejemplares similares

One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre
por: Keogh, Rachel J., et al.
Publicado: (2021)

Increased platelet reactivity in patients with late-stage metastatic cancer
por: Cooke, Niamh M, et al.
Publicado: (2013)

The cost of cancer care: how far would you go for a trial?
por: Fitzpatrick, Orla M., et al.
Publicado: (2022)

Chemotherapy in the Covid-19 era: the patient’s perception
por: Hennessy, Maeve A., et al.
Publicado: (2021)

Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013)

COVID-19-related mortality in cancer patients in an Irish setting
por: Linehan, Anna, et al.
Publicado: (2021)

Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2014)

Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2013)

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
por: Cloughesy, Timothy F, et al.
Publicado: (2020)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
por: Glynn, Aisling M., et al.
Publicado: (2019)

The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review
por: Poku, Edith, et al.
Publicado: (2014)

TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
por: Liu, Cheng-Jiang, et al.
Publicado: (2021)

An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer
por: Rashed, Ahmed, et al.
Publicado: (2023)

Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon Adenocarcinoma
por: Smyth, Robert J., et al.
Publicado: (2021)

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER”
por: Keegan, Niamh M., et al.
Publicado: (2021)

Primary brain tumours following breast cancer
por: Hussain, M, et al.
Publicado: (2015)

Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy
por: Schuster, Cornelia, et al.
Publicado: (2018)

Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up
por: El Matri, Leila, et al.
Publicado: (2021)

Oesophageal cancer metastases: An observational study of a more aggressive approach
por: Pickett, Lianne, et al.
Publicado: (2022)

Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer
por: Ogita, Shin, et al.
Publicado: (2012)

Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
por: Shoeibi, Nasser, et al.
Publicado: (2018)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
por: Singh, Sumit Randhir, et al.
Publicado: (2019)

Observable player behaviours and playing performance following helmet strikes in elite cricket
por: O'Halloran, Patrick, et al.
Publicado: (2021)

Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety
por: O’Halloran, Niamh, et al.
Publicado: (2017)

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using (111)In-bevacizumab
por: Patel, Neel, et al.
Publicado: (2017)

Delivery of systemic anti-cancer therapy during the COVID-19 pandemic
por: Fitzpatrick, Orla, et al.
Publicado: (2021)

Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy
por: Yap, Aaron, et al.
Publicado: (2022)

1571P Chemotherapy in the COVID-19 era: The patient’s perception
por: Hennessy, M., et al.
Publicado: (2020)

Combination of bevacizumab and photodynamic therapy vs. bevacizumab monotherapy for the treatment of wet age-related macular degeneration: A meta-analysis of randomized controlled trials
por: Wei, Qingquan, et al.
Publicado: (2018)

Confirmation of suboptimal protocols in spinal immobilisation?
por: Dixon, Mark, et al.
Publicado: (2015)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
por: Kalachand, Roshni D., et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer
por: Elsea, David, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension
por: Schuster, Cornelia, et al.
Publicado: (2012)

Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
por: Das, Gopal K., et al.
Publicado: (2018)

Oncological Risk in Autologous Stem Cell Donation for Novel Tissue-Engineering Approaches to Postmastectomy Breast Regeneration
por: O’Halloran, Niamh, et al.
Publicado: (2019)

Correction to: Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer
por: Elsea, David, et al.
Publicado: (2022)

Targeting the apoptosis pathway to treat tumours of the paediatric nervous system
por: Fitzgerald, Marie-Claire, et al.
Publicado: (2022)

Effects of lipopolysaccharide-induced inflammation on expression of growth-associated genes by corticospinal neurons
por: Hossain-Ibrahim, MK, et al.
Publicado: (2006)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
por: Nicoară, Simona Delia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d2d8u4ar1p3grtq3cslsr5l5rv